A small molecule inhibitor, SMIP34, that blocks the oncogenic activities of PELP1 has been discovered in our previously published study which shows that SMIP34 blocks the oncogenic activities of PELP1 in ER + BC [14]. Here, PELP1 is linked to breast cancer.